A new study sought to identify the frequency and determinants of flares for with people with systemic lupus erythematosus (SLE) with persistently active disease (PAD). Researchers found that both ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
March is here, and as we observe Kidney Month, it’s crucial to raise awareness about how lupus can severely impact the kidneys.
In a new study, researchers investigated microRNA-203 as a potential biomarker for lupus nephritis (LN) and found that ...
Join lupus warriors from all over the country for the nation's largest lupus advocacy event of the year! The Lupus Foundation of America's National Lupus Advocacy Summit will take place May 4-6, 2025 ...
Ready to connect with a supportive community? Don't miss out on the Pittsburgh Support Group led by dedicated facilitators Jaime Miller and Katlyn Lenz-Zanis. The Lupus Foundation of America works to ...
Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase ...
People with systemic lupus erythematosus (SLE) often face irreversible organ damage due to uncontrolled disease activity, frequent disease flares, and long-term glucocorticoid treatment. A recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback